<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PTPI
Petros Pharmaceuticals
$
()


  • Petros announces results from STENDRA pivotal consumer self-selection study

    7/16/2024 - 09:09am
  • Petros Pharmaceuticals completes human factors study of AI-integrated web app

    5/29/2024 - 09:28am
  • Petros forms advisory committee to guide Rx-to-OTC switch for STENDRA

    5/21/2024 - 09:26am
  • Petros Pharmaceuticals launches U.S. distribution of STENDRA

    5/14/2024 - 09:20am
  • 23andMe's Lemonaid Health collabs with Petros Pharmaceuticals

    5/14/2024 - 07:24am
  • Petros Pharmaceuticals files $100M mixed securities shelf

    5/3/2024 - 17:03pm
  • Petros Pharmaceuticals expands online distribution for prescription STENDRA

    4/23/2024 - 09:32am
  • Petros Pharmaceuticals expands online distribution for prescription STENDRA

    4/23/2024 - 09:20am
  • Petros report 'positive' FDA feedback after informal technology component review

    4/16/2024 - 09:25am
  • Petros Pharmaceuticals launches AI tool in collaboration with software provider

    3/19/2024 - 09:11am
  • Petros Pharmaceuticals enters AI-licensing agreement with software provider

    2/14/2024 - 09:34am
  • Petros Pharmaceuticals announces two upcoming FDA meetings on STENDRA

    1/24/2024 - 09:21am
  • Petros completes initial cohort of Phase 2 equivalent SSS for STENDRA

    1/17/2024 - 09:08am
  • Petros Pharmaceuticals completes Human Factors Study for STENDRA

    12/12/2023 - 10:06am
  • Petros Pharmaceuticals initiated with bullish view at Maxim

    12/8/2023 - 07:40am
dynamic_feed Breaking News